Surgical Sealants, Adhesives and Hemostats Global Market-Forecast to 2029

Publishing Date : September, 2022
Report Code : HCMD0175
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

 

Surgical sealants, adhesives, and hemostats (SAH) are the products used to close surgical incisions, post-surgical application, block the passage of fluids through the surface or openings of the wounds, and also to avoid microbial adhesions and infections. Sealants and adhesives are usually considered together as they both adhere to and seal the surgical incisions, while, hemostats are used to achieve hemostasis when the conventional method is ineffective and impractical.

According to IQ4I analysis, the SAH global market is expected to grow at mid-single digit CAGR from 2022 to 2029 to reach $4,366.0 million by 2029. The SAH global market is mainly segmented based on products, applications, end-users, and based on geography. The product market is segmented into sealant, adhesive and hemostat. Among these, the hemostat accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The sealants are further segmented based on their origin into natural and synthetic sealants. The synthetic sealant accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The natural sealants are further sub-segmented based on composition into fibrin and albumin sealants. Among them, fibrin accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic sealants are further segmented based on composition into cyanoacrylate, hydrogels, and others. Among them, hydrogels accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. The adhesive market is segmented into natural and synthetic adhesives, among them; synthetic adhesives accounted for the largest revenue in 2022 and are expected to grow at low-single digit CAGR from 2022 to 2029. The natural adhesives are further sub-segmented based on composition into fibrin and albumin, among them, fibrin adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic adhesives are further segmented based on composition into cyanoacrylate and polyurethane. The cyanoacrylate adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. Hemostats are classified based on function into mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants hemostats, among them, the mechanical hemostats accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. Fibrin sealant hemostat is the fastest growing segment at high-single digit strong CAGR from 2022 to 2029 because it is unique, powerful and effective for localized and diffused bleeding during surgical procedures.

The application market is segmented into Cardiovascular surgery, General Surgery, Orthopedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others. The general surgery segment accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029, because of high demand for various surgical procedures. Cosmetic surgery is the fastest growing segment at high-single digit CAGR, because of the advancements in treatment regimes available and better cosmetic outcomes.

The end-users market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment accounted for the largest share in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029, due to an increase in the aging population, increase in surgical procedural volumes, and better patient care services with advanced facilities.

Some of the major players in the SAH market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), Integra Lifescience (U.S.), B.Braun Melsungen AG (Germany), Teleflex (U.S.), Medtronic Plc (Ireland), Artivion Inc. (Cryolife) (U.S.), Advanced Medical Solutions Group Plc (U.K.), Tissium (France), Corza Medical, Inc. (U.S.), Healthium (India), Meril Lifesciences (India), Hemostasis (U.S.), Stryker (U.S.), and Terumo (Japan).

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET SIZE ESTIMATION
      • 2.6.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.6.3     SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASING DEMAND FOR SURGICAL PROCEDURES BOOSTS SAH MARKET GROWTH
        • 3.3.1.2     THE EMERGENCE OF TECHNICALLY ADVANCED PRODUCTS
        • 3.3.1.3     INCREASING GERIATRIC POPULATION
        • 3.3.1.4     ACQUISITION TO OPEN AN ARRAY OF OPPORTUNITIES FOR THE MARKET TO FLOURISH
        • 3.3.1.5     ACCEPTANCE OF SAH AND MARKET EXPANSION IN EMERGING NATIONS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     PITFALLS IN THE USAGE OF SAH
        • 3.3.2.2     EXPENSIVE SAH IMPEDING EFFECTIVE PENETRATION IN LOW AND MIDDLE-INCOME COUNTRIES
        • 3.3.2.3     UNFAVORABLE REIMBURSEMENT POLICIES IN DEVELOPING NATIONS
        • 3.3.2.4     STRINGENT REGULATORY GUIDELINES
        • 3.3.2.5     AVAILABILITY OF ALTERNATIVE PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
        • 3.4.1.1     ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM
        • 3.4.1.2     ISO 14644-1 CLEANROOM STANDARDS
        • 3.4.1.3     ISO 13485 MEDICAL DEVICES
        • 3.4.1.4     ISO 10993 BIOLOGICAL EVALUATION OF MEDICAL DEVICES
      • 3.4.2     ASTM INTERNATIONAL STANDARDS
      • 3.4.3     U.S.
      • 3.4.4     CANADA
      • 3.4.5     EUROPE
      • 3.4.6     JAPAN
      • 3.4.7     CHINA
      • 3.4.8     INDIA
    • 3.5     TECHNOLOGICAL ADVANCEMENTS
      • 3.5.1     BIOGLUE
      • 3.5.2     BIOINSPIRED GLUE FROM BARNACLES
      • 3.5.3     SNAKE-DERIVED SUPER GLUE
      • 3.5.4     ALGA MIMETIC TECHNOLOGY
      • 3.5.5     A POLYMER PATCH FOR THE ABDOMINAL CAVITY
    • 3.6     CLINICAL TRIALS
    • 3.7     FUNDING SCENARIO
    • 3.8     PORTER’S FIVE FORCE ANALYSIS
      • 3.8.1     THREAT OF NEW ENTRANTS
      • 3.8.2     THREAT OF SUBSTITUTES
      • 3.8.3     BARGAINING POWER OF SUPPLIERS
      • 3.8.4     BARGAINING POWER OF BUYERS
      • 3.8.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.9     SUPPLY CHAIN ANALYSIS
    • 3.10     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
      • 3.10.1     SAH GLOBAL MARKET SHARE ANALYSIS
      • 3.10.2     SURGICAL SEALANTS GLOBAL MARKET SHARE ANALYSIS
      • 3.10.3     SURGICAL ADHESIVES GLOBAL MARKET SHARE ANALYSIS
      • 3.10.4     HEMOSTATS GLOBAL MARKET SHARE ANALYSIS
    • 3.11     SAH COMPANY MATRIX
  • 4     SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     SEALANTS
      • 4.2.1     NATURAL SEALANTS
        • 4.2.1.1     FIBRIN NATURAL SEALANTS
        • 4.2.1.2     ALBUMIN NATURAL SEALANTS
      • 4.2.2     SYNTHETIC SEALANTS
        • 4.2.2.1     CYANOACRYLATE
        • 4.2.2.2     HYDROGELS
        • 4.2.2.3     OTHERS
    • 4.3     ADHESIVES
      • 4.3.1     NATURAL ADHESIVES
        • 4.3.1.1     FIBRIN NATURAL ADHESIVES
        • 4.3.1.2     ALBUMIN NATURAL ADHESIVES
      • 4.3.2     SYNTHETIC ADHESIVES
        • 4.3.2.1     CYANOACRYLATE
        • 4.3.2.2     POLYURETHANE
    • 4.4     HEMOSTATS
      • 4.4.1     MECHANICAL HEMOSTATS
      • 4.4.2     ACTIVE HEMOSTATS
      • 4.4.3     FLOWABLE HEMOSTATS
      • 4.4.4     FIBRIN SEALANT HEMOSTATS
  • 5     SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     CARDIOVASCULAR SURGERY
    • 5.3     GENERAL SURGERY
    • 5.4     ORTHOPEDIC SURGERY
    • 5.5     UROLOGY
    • 5.6     PULMONOLOGY
    • 5.7     NEUROSURGERY
    • 5.8     GYNECOLOGY
    • 5.9     COSMETIC SURGERY
    • 5.10     OTHERS
  • 6     SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     AMBULATORY SURGICAL CENTERS
    • 6.4     OTHERS
  • 7     SURGICAL SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET, BASED ON REGION
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     THE U.S.
      • 7.2.2     REST OF NORTH AMERICA
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     THE U.K.
      • 7.3.3     FRANCE
      • 7.3.4     REST OF E.U.
    • 7.4     APAC
      • 7.4.1     JAPAN
      • 7.4.2     CHINA
      • 7.4.3     INDIA
      • 7.4.4     REST OF APAC
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATAM
      • 7.5.3     MIDDLE EAST AND OTHERS
  • 8     MAJOR COMPANIES
    • 8.1     ADVANCED MEDICAL SOLUTIONS
      • 8.1.1     OVERVIEW
      • 8.1.2     FINANCIALS
      • 8.1.3     PRODUCT PORTFOLIO
      • 8.1.4     KEY DEVELOPMENTS
      • 8.1.5     BUSINESS STRATEGY
      • 8.1.6     SWOT ANALYSIS
    • 8.2     ARTIVION
      • 8.2.1     OVERVIEW
      • 8.2.2     FINANCIALS
      • 8.2.3     PRODUCT PORTFOLIO
      • 8.2.4     KEY DEVELOPMENTS
      • 8.2.5     BUSINESS STRATEGY
      • 8.2.6     SWOT ANALYSIS
    • 8.3     BAXTER INTERNATIONAL, INC
      • 8.3.1     OVERVIEW
      • 8.3.2     FINANCIALS
      • 8.3.3     PRODUCT PORTFOLIO
      • 8.3.4     KEY DEVELOPMENTS
      • 8.3.5     BUSINESS STRATEGY
      • 8.3.6     SWOT ANALYSIS
    • 8.4     B.BRAUN MELSUNGEN AG
      • 8.4.1     OVERVIEW
      • 8.4.2     FINANCIALS
      • 8.4.3     PRODUCT PORTFOLIO
      • 8.4.4     KEY DEVELOPMENTS
      • 8.4.5     BUSINESS STRATEGY
      • 8.4.6     SWOT ANALYSIS
    • 8.5     BECTON, DICKINSON AND COMPANY (C.R.BARD INC.)
      • 8.5.1     OVERVIEW
      • 8.5.2     FINANCIALS
      • 8.5.3     PRODUCT PORTFOLIO
      • 8.5.4     KEY DEVELOPMENTS
      • 8.5.5     BUSINESS STRATEGY
      • 8.5.6     SWOT ANALYSIS
    • 8.6     CORZA MEDICAL
      • 8.6.1     OVERVIEW
      • 8.6.2     FINANCIALS
      • 8.6.3     PRODUCT PORTFOLIO
      • 8.6.4     KEY DEVELOPMENTS
      • 8.6.5     BUSINESS STRATEGY
      • 8.6.6     SWOT ANALYSIS
    • 8.7     INTEGRA LIFESCIENCE
      • 8.7.1     OVERVIEW
      • 8.7.2     FINANCIALS
      • 8.7.3     PRODUCT PORTFOLIO
      • 8.7.4     KEY DEVELOPMENTS
      • 8.7.5     BUSINESS STRATEGY
      • 8.7.6     SWOT ANALYSIS
    • 8.8     JOHNSON & JOHNSON (ETHICON)
      • 8.8.1     OVERVIEW
      • 8.8.2     FINANCIALS
      • 8.8.3     PRODUCT PORTFOLIO
      • 8.8.4     KEY DEVELOPMENTS
      • 8.8.5     BUSINESS STRATEGY
      • 8.8.6     SWOT ANALYSIS
    • 8.9     MEDTRONIC, PLC
      • 8.9.1     OVERVIEW
      • 8.9.2     FINANCIALS
      • 8.9.3     PRODUCT PORTFOLIO
      • 8.9.4     KEY DEVELOPMENTS
      • 8.9.5     BUSINESS STRATEGY
      • 8.9.6     SWOT ANALYSIS
    • 8.10     TELEFLEX
      • 8.10.1     OVERVIEW
      • 8.10.2     FINANCIALS
      • 8.10.3     PRODUCT PORTFOLIO
      • 8.10.4     KEY DEVELOPMENTS
      • 8.10.5     BUSINESS STRATEGY
      • 8.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 2     SAH GLOBAL MARKET REVENUE, BASED ON PRODUCTS, (2021-2029) ($MN)
      • TABLE 3     SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 4     SEALANTS GLOBAL MARKET REVENUE, BASED ON ORIGIN, (2021-2029) ($MN)
      • TABLE 5     NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 6     NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 7     FIBRIN NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 8     ALBUMIN NATURAL SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 9     SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 10     SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 11     CYANOACRYLATE SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 12     HYDROGEL SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 13     OTHER SYNTHETIC SEALANTS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 14     ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 15     ADHESIVES GLOBAL MARKET REVENUE, BASED ON ORIGIN, (2021-2029) ($MN)
      • TABLE 16     NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 17     NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 18     FIBRIN NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 19     ALBUMIN NATURAL ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 20     SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 21     SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 22     CYANOACRYLATE SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 23     POLYURETHANE SYNTHETIC ADHESIVES GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 24     HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 25     HEMOSTATS GLOBAL MARKET REVENUE, BASED ON FUNCTION, (2021-2029) ($MN)
      • TABLE 26     MECHANICAL HEMOSTAT GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 27     ACTIVE HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 28     FLOWABLE HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 29     FIBRIN SEALANT HEMOSTATS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 30     SAH GLOBAL MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
      • TABLE 31     CARDIOVASCULAR SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 32     GENERAL SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 33     ORTHOPEDIC SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 34     UROLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 35     PULMONOLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 36     NEUROSURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 37     GYNECOLOGY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 38     COSMETIC SURGERY SAH APPLICATION GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 39     OTHER SAH APPLICATIONS GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 40     SAH GLOBAL MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
      • TABLE 41     HOSPITALS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 42     AMBULATORY SURGICAL CENTERS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 43     OTHER END-USERS SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 44     SAH GLOBAL MARKET REVENUE, BASED ON REGION, (2021-2029) ($MN)
      • TABLE 45     NORTH AMERICA SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
      • TABLE 46     NORTH AMERICA SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 47     NORTH AMERICA NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 48     NORTH AMERICA SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 49     NORTH AMERICA ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 50     NORTH AMERICA NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 51     NORTH AMERICA SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 52     NORTH AMERICA HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
      • TABLE 53     NORTH AMERICA SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
      • TABLE 54     NORTH AMERICA SAH MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
      • TABLE 55     NORTH AMERICA SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 56     EUROPE SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
      • TABLE 57     EUROPE SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 58     EUROPE NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 59     EUROPE SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 60     EUROPE ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 61     EUROPE NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 62     EUROPE SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 63     EUROPE HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
      • TABLE 64     EUROPE SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
      • TABLE 65     EUROPE SAH MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
      • TABLE 66     EUROPE SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 67     APAC SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
      • TABLE 68     APAC SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 69     APAC NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 70     APAC SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 71     APAC ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 72     APAC NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 73     APAC SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 74     APAC HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
      • TABLE 75     APAC SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
      • TABLE 76     APAC SAH MARKET REVENUE, BASED ON END USERS, (2021-2029) ($MN)
      • TABLE 77     APAC SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 78     ROW SAH MARKET REVENUE, BASED ON PRODUCTS (2021-2029) ($MN)
      • TABLE 79     ROW SEALANTS MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 80     ROW NATURAL SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 81     ROW SYNTHETIC SEALANTS MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 82     ROW ADHESIVES MARKET REVENUE, BASED ON ORIGIN (2021-2029) ($MN)
      • TABLE 83     ROW NATURAL ADHESIVES MARKET REVENUE, BASED ON COMPOSITION (2021-2029) ($MN)
      • TABLE 84     ROW SYNTHETIC ADHESIVES MARKET REVENUE, BASED ON COMPOSITION, (2021-2029) ($MN)
      • TABLE 85     ROW HEMOSTATS MARKET REVENUE, BASED ON FUNCTION (2021-2029) ($MN)
      • TABLE 86     ROW SAH MARKET REVENUE, BASED ON APPLICATION, (2021-2029) ($MN)
      • TABLE 87     ROW SAH MARKET REVENUE, BASED ON END-USERS, (2021-2029) ($MN)
      • TABLE 88     ROW SAH MARKET REVENUE, BASED ON COUNTRY, (2021-2029) ($MN)
      • TABLE 89     ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 90     ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) ($MN)
      • TABLE 91     ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2019-2021) ($MN)
      • TABLE 92     ADVANCED MEDICAL SOLUTIONS: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 93     ARTIVION: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
      • TABLE 94     ARTIVION: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 95     ARTIVION: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 96     ARTIVION: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
      • TABLE 97     BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
      • TABLE 98     BAXTER INTERNATIONAL, INC.: TOTAL SALES, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 99     BAXTER INTERNATIONAL, INC.: TOTAL SALES, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
      • TABLE 100     B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
      • TABLE 101     B.BRAUN MELSENGEN AG: TOTAL REVENUE, BASED ON SEGMENTS, (2019-2021) ($MN)
      • TABLE 102     B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BASED ON GEOGRAPHY, (2019-2021) ($MN)
      • TABLE 103     BD: TOTAL REVENUE AND R&D EXPENSES, (2020-2022)(Q2) ($MN)
      • TABLE 104     BD: TOTAL REVENUE BASED ON SEGMENTS, (2020-2022)(Q2) ($MN)
      • TABLE 105     BD: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q2) ($MN)
      • TABLE 106     INTEGRA LIFESCIENCE: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
      • TABLE 107     INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 108     INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON SUB-SEGMENTS, (2020-2022)(Q1) ($MN)
      • TABLE 109     INTEGRA LIFESCIENCE: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
      • TABLE 110     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q1) ($MN)
      • TABLE 111     JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 112     JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON SUBSEGMENTS, (2020-2022) (Q1) ($MN)
      • TABLE 113     JOHNSON & JOHNSON: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)
      • TABLE 114     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) ($MN)
      • TABLE 115     MEDTRONIC, PLC: TOTAL REVENUE, BASED ON SEGMENTS (2020-2022) ($MN)
      • TABLE 116     MEDTRONIC, PLC: TOTAL REVENUE, BASED ON SUB-SEGMENTS, (2020-2022) ($MN)
      • TABLE 117     MEDTRONIC, PLC: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) ($MN)
      • TABLE 118     TELEFLEX: TOTAL REVENUE AND R&D EXPENSES, (2020-2022) (Q2) ($MN)
      • TABLE 119     TELEFLEX: TOTAL REVENUE, BASED ON SEGMENTS, (2020-2022) (Q2) ($MN)
      • TABLE 120     TELEFLEX: TOTAL REVENUE, BASED ON GEOGRAPHY, (2020-2022) (Q1) ($MN)

      LIST OF FIGURES

      • FIGURE 1     SAH GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: SAH GLOBAL MARKET
      • FIGURE 3     SAH GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     SAH GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     SAH GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     SAH GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     SAH GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     SAH GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     SAH GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
      • FIGURE 11     SURGICAL SEALANTS GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
      • FIGURE 12     SURGICAL ADHESIVES GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
      • FIGURE 13     HEMOSTATS GLOBAL MARKET SHARE ANALYSIS, BASED ON KEY PLAYERS, 2022 (%)
      • FIGURE 14     SAH GLOBAL MARKET SHARE, BASED ON PRODUCTS (2022 V/S 2029) (%)
      • FIGURE 15     SEALANTS GLOBAL MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 16     NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
      • FIGURE 17     NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 18     FIBRIN NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
      • FIGURE 19     ALBUMIN NATURAL SEALANTS GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
      • FIGURE 20     SYNTHETIC SEALANTS GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 21     OTHER SYNTHETIC SEALANT GLOBAL MARKET SHARE, BASED ON REGION, (2022 V/S 2029) (%)
      • FIGURE 22     ADHESIVES GLOBAL MARKET SHARE, BASED ON ORIGIN, (2022 V/S 2029) (%)
      • FIGURE 23     NATURAL ADHESIVES GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 24     SYNTHETIC ADHESIVES GLOBAL MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 25     HEMOSTATS GLOBAL MARKET SHARE, BASED ON FUNCTION (2022 V/S 2029) (%)
      • FIGURE 26     SAH GLOBAL MARKET SHARE, BASED ON APPLICATION, (2022) (%)
      • FIGURE 27     SAH GLOBAL MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
      • FIGURE 28     SAH GLOBAL MARKET REVENUE, BASED ON REGION (2021-2029) ($MN) CAGR (%)
      • FIGURE 29     SAH GLOBAL MARKET SHARE AND REVENUE BASED ON COUNTRY (2022) (%) ($MN)
      • FIGURE 30     NORTH AMERICA SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
      • FIGURE 31     NORTH AMERICA SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 32     NORTH AMERICA NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 33     NORTH AMERICA SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 34     NORTH AMERICA ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 35     NORTH AMERICA NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 36     NORTH AMERICA SYNTHETIC ADHESIVES MARKET SHARE BASED ON COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 37     NORTH AMERICA HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
      • FIGURE 38     NORTH AMERICA SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
      • FIGURE 39     NORTH AMERICA SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
      • FIGURE 40     NORTH AMERICA SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
      • FIGURE 41     U.S. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 42     U.S. SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 43     REST OF N.A. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 44     REST OF N.A. SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 45     EUROPE SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
      • FIGURE 46     EUROPE SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 47     EUROPE NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 48     EUROPE SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 49     EUROPE ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 50     EUROPE NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 51     EUROPE SYNTHETIC ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 52     EUROPE HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
      • FIGURE 53     EUROPE SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
      • FIGURE 54     EUROPE SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
      • FIGURE 55     EUROPE SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
      • FIGURE 56     GERMANY SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 57     GERMANY SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 58     U.K. SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 59     U.K. SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 60     FRANCE SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 61     FRANCE SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 62     REST OF EUROPE SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 63     REST OF EUROPE SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 64     APAC SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
      • FIGURE 65     APAC SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 66     APAC NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 67     APAC SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 68     APAC ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 69     APAC NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 70     APAC SYNTHETIC ADHESIVES MARKET SHARE BASED COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 71     APAC HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
      • FIGURE 72     APAC SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
      • FIGURE 73     APAC SAH MARKET SHARE, BASED ON END USERS, (2022 V/S 2029) (%)
      • FIGURE 74     APAC SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
      • FIGURE 75     JAPAN SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 76     JAPAN SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 77     CHINA SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 78     CHINA SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 79     INDIA SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 80     INDIA SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 81     REST OF APAC SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS,(2022 V/S 2029) ($MN)
      • FIGURE 82     REST OF APAC SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 83     ROW SAH MARKET SHARE, BASED ON PRODUCT, (2022 V/S 2029) (%)
      • FIGURE 84     ROW SEALANTS MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 85     ROW NATURAL SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 86     ROW SYNTHETIC SEALANTS MARKET SHARE, BASED ON COMPOSITION (2022 V/S 2029) (%)
      • FIGURE 87     ROW ADHESIVES MARKET SHARE, BASED ON ORIGIN (2022 V/S 2029) (%)
      • FIGURE 88     ROW NATURAL ADHESIVES MARKET SHARE, BASED ON COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 89     ROW SYNTHETIC ADHESIVES MARKET SHARE BASED COMPOSITION, (2022 V/S 2029) (%)
      • FIGURE 90     ROW HEMOSTATS MARKET SHARE, BASED ON FUNCTION, (2022 V/S 2029) (%)
      • FIGURE 91     ROW SAH MARKET SHARE, BASED ON APPLICATION, (2022) (%)
      • FIGURE 92     ROW SAH MARKET SHARE, BASED ON END-USERS, (2022 V/S 2029) (%)
      • FIGURE 93     ROW SAH MARKET SHARE, BASED ON COUNTRY, (2022 V/S 2029) (%)
      • FIGURE 94     BRAZIL SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 95     BRAZIL SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 96     REST OF LATAM SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 97     REST OF LATAM SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 98     MIDDLE EAST & OTHERS SAH MARKET REVENUE, BASED ON PRODUCTS AND APPLICATIONS, (2022 V/S 2029) ($MN)
      • FIGURE 99     MIDDLE EAST & OTHERS SAH MARKET REVENUE, BASED ON END-USERS, (2022 V/S 2029) ($MN)
      • FIGURE 100     SWOT: ADVANCED MEDICAL SOLUTIONS
      • FIGURE 101     SWOT: ARTIVION
      • FIGURE 102     SWOT: BAXTER INTERNATIONAL, INC.
      • FIGURE 103     SWOT: B.BRAUN MELSUNGEN, AG
      • FIGURE 104     SWOT: BD (C.R.BARD, INC.)
      • FIGURE 105     SWOT: CORZA MEDICAL
      • FIGURE 106     SWOT: INTEGRA LIFESCIENCE
      • FIGURE 107     SWOT: JOHNSON & JOHNSON (ETHICON)
      • FIGURE 108     SWOT: MEDTRONIC, PLC
      • FIGURE 109     SWOT: TELEFLEX

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ADHEZION BIOMEDICAL, LLC
      • 2     ADVANCED MEDICAL SOLUTIONS GROUP PLC (SELANTIS)
      • 3     AEGIS-LIFESCIENCES
      • 4     ARTIVION (CRYOLIFE)
      • 5     AXIO BIOSCIENCE
      • 6     B.BRAUN MELSUNGEN AG
      • 7     BAXTER INTERNATIONAL, INC.
      • 8     BECTON DICKINSON AND COMPANY (TISSUMED)
      • 9     BEAVER VISITEC INTERNATIONAL
      • 10     BETATECH MEDICAL
      • 11     BIOCER ENTWICKLUNGS-GMBH
      • 12     BIOM’UP
      • 13     BOZ MEDICAL
      • 14     CHEMENCE MEDICAL, INC.
      • 15     CORZA MEDICAL
      • 16     CSL BEHRING
      • 17     DALIM TISSEN
      • 18     DSI LTD
      • 19     EQUIMEDICAL
      • 20     GATT TECH
      • 21     GELITA MEDICAL
      • 22     GEM SRL
      • 23     GLUSTITICH, INC.
      • 24     GREEN CROSS BIOPHARMA
      • 25     GRENA
      • 26     GRUNENTHAL GMBH (ADHESYS MEDICAL GMBH)
      • 27     H.B. FULLER
      • 28     HAGER & WERKEN GMBH & CO. KG
      • 29     HAULAN BIOENGINEERING CO LTD
      • 30     HEALTHIUM
      • 31     HEMARUS THERAPEUTICS
      • 32     HEMOSTATIS
      • 33     IBC PHARMACEUTICALS, LTD.
      • 34     INTEGRA LIFESCIENCES HOLDING CORPORATION
      • 35     JOHNSON & JOHNSON (ETHICON)
      • 36     KATSAN MEDICAL DEVICES
      • 37     MEDTRONIC
      • 38     MERIL LIFE SCIENCES PVT. LTD
      • 39     OCULAR THERAPEUTIX, INC.
      • 40     OPTMED, INC.
      • 41     PETER SURGICAL
      • 42     PFIZER
      • 43     RELIANCE LIFESCIENCE
      • 44     SAMYANG HOLDINGS CORPORATION
      • 45     SHANGHAI RAAS
      • 46     STARSIL HEMOSTAT
      • 47     STRYKER
      • 48     SYMATESE
      • 49     TELEFLEX
      • 50     TERUMO CORPORATION
      • 51     THERACION BIOMEDICAL
      • 52     TISSIUM (GECKO MEDICAL)
      • 53     TRICOL BIOMEDICAL
      • 54     VIVOSTAT A/S
      • 55     WORTHAM LABORATORIES INC
      • 56     ZHEJIANG PERFECTSEAL